292 related articles for article (PubMed ID: 29214579)
1. Cost-of-Illness in Rare Diseases.
Linertová R; García-Pérez L; Gorostiza I
Adv Exp Med Biol; 2017; 1031():283-297. PubMed ID: 29214579
[TBL] [Abstract][Full Text] [Related]
2. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
Hu H; Luan L; Yang K; Li SC
Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
[TBL] [Abstract][Full Text] [Related]
3. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence.
Angelis A; Tordrup D; Kanavos P
Health Policy; 2015 Jul; 119(7):964-79. PubMed ID: 25661982
[TBL] [Abstract][Full Text] [Related]
4. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis.
Aranda-Reneo I; Rodríguez-Sánchez B; Peña-Longobardo LM; Oliva-Moreno J; López-Bastida J
Value Health; 2021 Mar; 24(3):431-442. PubMed ID: 33641778
[TBL] [Abstract][Full Text] [Related]
5. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of irritable bowel syndrome in China.
Zhang F; Xiang W; Li CY; Li SC
World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
[TBL] [Abstract][Full Text] [Related]
7. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008.
Petříková A; Doležal T; Klimeš J; Vocelka M; Sedová L; Kolář J
Rheumatol Int; 2013 Jul; 33(7):1813-9. PubMed ID: 23314983
[TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
[TBL] [Abstract][Full Text] [Related]
11. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
Łyszczarz B; Nojszewska E
BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of depression in Sweden from 1997 to 2005.
Sobocki P; Lekander I; Borgström F; Ström O; Runeson B
Eur Psychiatry; 2007 Apr; 22(3):146-52. PubMed ID: 17194573
[TBL] [Abstract][Full Text] [Related]
13. A health economic lifetime treatment pathway model for low back pain in Sweden.
Olafsson G; Jonsson E; Fritzell P; Hägg O; Borgström F
J Med Econ; 2017 Dec; 20(12):1281-1289. PubMed ID: 28840772
[TBL] [Abstract][Full Text] [Related]
14. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
15. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of moderate to severe plaque psoriasis in Canada.
Levy AR; Davie AM; Brazier NC; Jivraj F; Albrecht LE; Gratton D; Lynde CW
Int J Dermatol; 2012 Dec; 51(12):1432-40. PubMed ID: 23171010
[TBL] [Abstract][Full Text] [Related]
18. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
Ghushchyan V; Nair KV; Page RL
Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
[TBL] [Abstract][Full Text] [Related]
19. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
Png ME; Yoong J; Phan TP; Wee HL
BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
[TBL] [Abstract][Full Text] [Related]
20. Economic burden from smoking-related diseases in Thailand.
Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]